Figure 1. Fusion images (ultrasound imaging in grayscale and photoacoustic imaging in color) of beads targeted with composite nanoparticles and trapped in a 12mL/min flow stream at different time points of magnetic action. Triangles indicate the position of the magnet.
absorption properties. 13 Specifically, multifunctional nanometer-scale composite contrast agents consisting of a highly optical absorptive gold nanorod coupled with magnetic nanospheres can be chemically linked (i.e., targeted) to diseased cells. With an efficient magnetic trapping system, targeted cells can be accumulated, manipulated, and then differentiated from the non-magnetic background by motion filtering. This noninvasive technique is particularly interesting for clinical applications as it can sample large blood volumes in a short exam time while providing a real-time readout.
We recently presented the results of two initial tests of this technology in the Journal of Biomedical Optics. 14, 15 One of the methods we explored, presented here, examined the trapping, imaging, and manipulation of polystyrene beads (10 m in diameter) targeted with a composite contrast agent. These beads mimic targeted CTCs and were circulated in a 1.6mm polytetrafluoroethylene tube to simulate CTCs moving in the peripheral vasculature. Figure 1 shows ultrasound/PA fusion images: the process of trapping targeted beads in a right-toleft stream with a flow rate of 12ml/min (twice that in the human radial artery). Ultrasound signals are displayed in grayscale, whereas PA signals are superimposed in 'hot' pseudocolor. The top and bottom tube boundaries can be clearly seen in the ultrasound image. Figure 1(b)-(g) illustrates the course of the experiment: after applying the magnetic force (at time=0), beads gradually accumulated at the bottom of the tube owing to the strong trapping force; the PA signal amplitude increased correspondingly. The beads were released in Figure 1(h) by removing the magnets.
We repeated the same experiment replacing the transparent medium with an ink solution, mimicking the optical absorption of blood. Figure 2 Figure 2(c) shows how, by applying a simple subtraction filter to produce the mmPA image, bead signals are preserved whereas ink signals are suppressed to overcome this problem. These results must be followed up with well-designed animal studies before considering clinical translation, and this is something we plan to do. However, our results do suggest that mmPA imaging with magnetic trapping of targeted rare cells might be an exciting tool to identify CTCs circulating in large blood vessels (e.g., the human radial and brachial arteries). By targeting these peripheral vessels, large blood volumes can be sampled in reasonable procedure times, enabling highly sensitive (<1CTC/mL of blood), and potentially highly specific, non-invasive monitoring of CTCs. Such a technology could be an invaluable tool in optimally managing metastatic disease.
